Drreddys Laboratories reported INR81.18B in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
ANI Pharmaceuticals USD 136.41M 6.74M Sep/2026
Aurora Cannabis CAD 187.54M 12.47M Jun/2026
Bayer EUR 11.97B 43M Jun/2026
Canopy Growth CAD 107.46M 3.06M Jun/2026
Cipla INR 67.78B 1.82B Sep/2026
Corcept Therapeutics USD 11.91M 1.28M Sep/2026
Drreddys Laboratories INR 81.18B 4.65B Sep/2026
GlaxoSmithKline GBP 6.28B 125M Jun/2026
Hikma Pharmaceutical USD 1.11B 24M Dec/2025
Lonza CHF 1.68B 163M Dec/2025
Novartis USD 6.1B 116M Sep/2026
Pacira USD 3.83B 3.69B Sep/2026
Phibro Animal Health USD 567.14M 32.26M Sep/2026
Prestige Brands USD 179.2M 11.01M Sep/2026
Richter Gedeon HUF 205.75B 9.76B Jun/2024
Sun Pharmaceuticals INR 114.93B 12.5B Mar/2026
Supernus Pharmaceuticals USD 113.24M 6.22M Sep/2026
Teva Pharmaceutical Industries USD 3.17B 48M Sep/2026